Paper28596754
Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines.
De Mello WC and 2 others. Front Endocrinol (Lausanne), 2017. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines. Papers, record 28596754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28596754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| G12 MD007600 | NIMHD NIH HHS | United States | G12MD007600 | PubMed and NIH | NIH RePORTER |
| SC1 NS095380 | NINDS NIH HHS | United States | SC1NS095380 | PubMed and NIH | NIH RePORTER |
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2455902 | Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2455902 | PubMed |
| 2 | 12089530 | Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. | Nat Neurosci | 2002 | https://conductscience.org/library/papers/12089530 | PubMed |
| 3 | 8666063 | Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders. | Eur J Pharmacol | 1996 | https://conductscience.org/library/papers/8666063 | PubMed |
| 4 | 12456490 | Superoxide mediates the actions of angiotensin II in the central nervous system. | Circ Res | 2002 | https://conductscience.org/library/papers/12456490 | PubMed |
| 5 | 25445565 | Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration. | Neurotoxicology | 2014 | https://conductscience.org/library/papers/25445565 | PubMed |
| 6 | 26044748 | Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease. | Mol Neurobiol | 2016 | https://conductscience.org/library/papers/26044748 | PubMed |
| 7 | 22590974 | The intracrine renin-angiotensin system. | Clin Sci (Lond) | 2012 | https://conductscience.org/library/papers/22590974 | PubMed |
| 8 | 11731527 | Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. | J Neurophysiol | 2001 | https://conductscience.org/library/papers/11731527 | PubMed |
| 9 | 21629717 | Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease. | Front Syst Neurosci | 2011 | https://conductscience.org/library/papers/21629717 | PubMed |
| 10 | 18443753 | Signalling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. | J Mol Med (Berl) | 2008 | https://conductscience.org/library/papers/18443753 | PubMed |
| 11 | 26886190 | Olmesartan Inhibits Cardiac Hypertrophy in Mice Overexpressing Renin Independently of Blood Pressure: Its Beneficial Effects on ACE2/Ang(1-7)/Mas Axis and NADPH Oxidase Expression. | J Cardiovasc Pharmacol | 2016 | https://conductscience.org/library/papers/26886190 | PubMed |
| 12 | 7478166 | Co-localization of angiotensin II and gamma-aminobutyric acid in axon terminals in the rat subfornical organ. | Neurosci Lett | 1995 | https://conductscience.org/library/papers/7478166 | PubMed |
| 13 | 25398321 | Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease. | Mol Neurodegener | 2014 | https://conductscience.org/library/papers/25398321 | PubMed |
| 14 | 22709585 | Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease. | Free Radic Biol Med | 2012 | https://conductscience.org/library/papers/22709585 | PubMed |
| 15 | 17299753 | Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. | J Comp Neurol | 2007 | https://conductscience.org/library/papers/17299753 | PubMed |
| 16 | 8055698 | Expression of the MAS proto-oncogene in the retinal pigment epithelium of the rhesus macaque. | Curr Eye Res | 1994 | https://conductscience.org/library/papers/8055698 | PubMed |
| 17 | 7735261 | Neurotransmitters and neuropeptides in the baroreceptor reflex arc: connections between the nucleus of the solitary tract and the ventrolateral medulla oblongata in the rat. | Clin Exp Hypertens | 1995 | https://conductscience.org/library/papers/7735261 | PubMed |
| 18 | 17158342 | On the pathophysiological implications of an intracellular renin receptor. | Circ Res | 2006 | https://conductscience.org/library/papers/17158342 | PubMed |
| 19 | 17965777 | Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17965777 | PubMed |
| 20 | 26303307 | Neuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and Pitfalls. | J Biomol Screen | 2015 | https://conductscience.org/library/papers/26303307 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40956543 | Neuroprotective effects of candesartan in 3-nitropropionic acid-induced Huntington's disease: modulation of angiotensin and CREB/BDNF/PGC1-α signaling. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40956543 | PubMed |
| 35887034 | Renin-Angiotensin System in Huntington's Disease: Evidence from Animal Models and Human Patients. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35887034 | PubMed |
| 31933441 | The Renin-Angiotensin System in Huntington's Disease: Villain or Hero? | Protein Pept Lett | 2020 | https://conductscience.org/library/papers/31933441 | PubMed |
| 31744868 | Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington's disease. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31744868 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGT | 183 | PubTator's text mining | https://conductscience.org/library/genes/183 | NCBI Gene |
| AGTR1 | 185 | PubTator's text mining | https://conductscience.org/library/genes/185 | NCBI Gene |
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28596754
GET https://conductscience.org/api/papers/v1/28596754/references?page=2